Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1081 - 1088 of 12040 results
EnforceMintz — COVID-19 Fraud Enforcement Unlikely to Slow Down in 2024
February 8, 2024| Blog| Viewpoint
ESG Political Partisanship: Guidance for In House Counsel
February 7, 2024| Podcast| Viewpoint
“What is Love? Baby, Don’t Sue Me: AB 1076 and California’s Quickly Approaching Valentine’s Day Notification Deadline”
February 7, 2024| Blog| Viewpoint
Finance 101: How to Fix Canada's Broken Universities
February 7, 2024| News
Mintz Venture Watch — Volume 6: A Report on Deal Trends from 2023
February 6, 2024| Article| Viewpoint
IRS Opens Registration Portal for the Elective Payment or Transfer of Tax Credits
February 6, 2024| Alert| Viewpoint
The FINRA Reports That May Foreshadow New AI Rules
February 6, 2024| News
The Irony Of Taxing 401k Plans To Save Social Security
February 6, 2024| News
News & Press Releases
Mintz Welcomes Corporate Member Ruth Jin in New York
July 21, 2025
Ruth Jin has joined Mintz as a Member in the firm’s Corporate Practice with a focus on investment fund formation, liquidity strategies, governance, investment transactions, and securities offerings.
San Francisco Business Times featured Mintz’s new office lease in San Francisco at 525 Market St. The firm will be increasing its footprint in downtown by 50% to 29,000 square feet on a whole single floor with the new space.
Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|